Prostate-specific Antigen (PSA) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 248784 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING INDUSTRY
    2.1 Summary about Prostate-specific Antigen (PSA) Testing Industry
    2.2 Prostate-specific Antigen (PSA) Testing Market Trends
        2.2.1 Prostate-specific Antigen (PSA) Testing Production & Consumption Trends
        2.2.2 Prostate-specific Antigen (PSA) Testing Demand Structure Trends
    2.3 Prostate-specific Antigen (PSA) Testing Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 CLIA Method
        4.2.2 ELISA Method
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Screening
        4.3.2 Post-treatment Monitoring
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 CLIA Method
        5.2.2 ELISA Method
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Screening
        5.3.2 Post-treatment Monitoring
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 CLIA Method
        6.2.2 ELISA Method
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Screening
        6.3.2 Post-treatment Monitoring
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 CLIA Method
        7.2.2 ELISA Method
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Screening
        7.3.2 Post-treatment Monitoring
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 CLIA Method
        8.2.2 ELISA Method
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Screening
        8.3.2 Post-treatment Monitoring
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 CLIA Method
        9.2.2 ELISA Method
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Screening
        9.3.2 Post-treatment Monitoring
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Abbott
        10.1.2 Boston Scientific Corporation
        10.1.3 Bayer AG
        10.1.4 Siemens Healthcare
        10.1.5 DiaSorin
        10.1.6 Roche
        10.1.7 Beckman Coulter
        10.1.8 PerkinElmer
        10.1.9 Tosoh
        10.1.10 Ortho Clinical
        10.1.11 Fujirebio
        10.1.12 Mediwatch
        10.1.13 BodiTech
        10.1.14 Bristol-Myers Squibb Company
        10.1.15 GE Healthcare
        10.1.16 Endocare
        10.1.17 Merck＆Co.
        10.1.18 Medtronic
        10.1.19 Sanofi-Aventis SA
    10.2  Prostate-specific Antigen (PSA) Testing Sales Date of Major Players (2017-2020e)
        10.2.1 Abbott
        10.2.2 Boston Scientific Corporation
        10.2.3 Bayer AG
        10.2.4 Siemens Healthcare
        10.2.5 DiaSorin
        10.2.6 Roche
        10.2.7 Beckman Coulter
        10.2.8 PerkinElmer
        10.2.9 Tosoh
        10.2.10 Ortho Clinical
        10.2.11 Fujirebio
        10.2.12 Mediwatch
        10.2.13 BodiTech
        10.2.14 Bristol-Myers Squibb Company
        10.2.15 GE Healthcare
        10.2.16 Endocare
        10.2.17 Merck＆Co.
        10.2.18 Medtronic
        10.2.19 Sanofi-Aventis SA
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Prostate-specific Antigen (PSA) Testing Product Type Overview
2.Table Prostate-specific Antigen (PSA) Testing Product Type Market Share List
3.Table Prostate-specific Antigen (PSA) Testing Product Type of Major Players
4.Table Brief Introduction of Abbott
5.Table Brief Introduction of Boston Scientific Corporation
6.Table Brief Introduction of Bayer AG
7.Table Brief Introduction of Siemens Healthcare
8.Table Brief Introduction of DiaSorin
9.Table Brief Introduction of Roche
10.Table Brief Introduction of Beckman Coulter
11.Table Brief Introduction of PerkinElmer
12.Table Brief Introduction of Tosoh
13.Table Brief Introduction of Ortho Clinical
14.Table Brief Introduction of Fujirebio
15.Table Brief Introduction of Mediwatch
16.Table Brief Introduction of BodiTech
17.Table Brief Introduction of Bristol-Myers Squibb Company
18.Table Brief Introduction of GE Healthcare
19.Table Brief Introduction of Endocare
20.Table Brief Introduction of Merck＆Co.
21.Table Brief Introduction of Medtronic
22.Table Brief Introduction of Sanofi-Aventis SA
23.Table Products & Services of Abbott
24.Table Products & Services of Boston Scientific Corporation
25.Table Products & Services of Bayer AG
26.Table Products & Services of Siemens Healthcare
27.Table Products & Services of DiaSorin
28.Table Products & Services of Roche
29.Table Products & Services of Beckman Coulter
30.Table Products & Services of PerkinElmer
31.Table Products & Services of Tosoh
32.Table Products & Services of Ortho Clinical
33.Table Products & Services of Fujirebio
34.Table Products & Services of Mediwatch
35.Table Products & Services of BodiTech
36.Table Products & Services of Bristol-Myers Squibb Company
37.Table Products & Services of GE Healthcare
38.Table Products & Services of Endocare
39.Table Products & Services of Merck＆Co.
40.Table Products & Services of Medtronic
41.Table Products & Services of Sanofi-Aventis SA
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Prostate-specific Antigen (PSA) Testing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Prostate-specific Antigen (PSA) Testing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Prostate-specific Antigen (PSA) Testing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Prostate-specific Antigen (PSA) Testing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Prostate-specific Antigen (PSA) Testing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Prostate-specific Antigen (PSA) Testing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Prostate-specific Antigen (PSA) Testing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure CLIA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure ELISA Method Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Screening Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Post-treatment Monitoring Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Abbott 2017-2020e
66.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Boston Scientific Corporation 2017-2020e
67.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Bayer AG 2017-2020e
68.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Siemens Healthcare 2017-2020e
69.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of DiaSorin 2017-2020e
70.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Roche 2017-2020e
71.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Beckman Coulter 2017-2020e
72.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of PerkinElmer 2017-2020e
73.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Tosoh 2017-2020e
74.Figure Prostate-specific Antigen (PSA) Testing Sales Revenue (Million USD) of Ortho Clinical 2017-2020e
75.Figure Prostate-spec
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Prostate-specific Antigen Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate-specific Antigen Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate-specific Antigen Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports